CCR2 and plasma cell myeloma: In light of this inter-species permissiveness, we assessed the pharmacological properties of mouse GMME1 on the human multiple myeloma cell line U266, a CD19-/- human myeloma cell line shown to express the plasma cell marker CD138 and CCR2 (Figure 4A).